1. DeGeorge JJ, Ahn CH, Andrews PA, Brower ME, Giorgio DW, Goheer MA, Lee-Ham DY, McGuinn WD, Schmidt W, Sun CJ, Tripathi SC (1998) Regulatory considerations for preclinical development of anticancer drugs. Cancer Chemother Pharmacol 41(3):173–185
2. EMA (1998) Committee for Proprietary Medicinal Products: Note for guideline on the pre-clinical evaluation of anticancer medicinal products; CPMP/SWP/997/96. EMA, London
3. EORTC New Drug Development Committee (1985) EORTC guidelines for Phase I trials with single agents in adults. Eur J Cancer Clin Oncol 21:1005–1007
4. Final Concept Paper (2007) S9: Preclinical guideline on oncology therapeutic development.
http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S9/Concept_papers/S9_Concept_Paper.pdf
. Accessed 21 Mar 2012
5. ICH S5 (R2) (2000) Detection of toxicity to reproduction for medicinal products & toxicity to male fertility.
http://www.ich.org/products/guidelines/safety/article/safety-guidelines.html
.